Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1143

Mar 19, 2022

You’re invited to join our subreddit community —

Posted by in categories: bioengineering, biotech/medical, cyborgs, genetics, nanotechnology, robotics/AI, singularity, transhumanism, virtual reality

R/IntelligenceSupernova — dedicated to techno-optimists, singularitarians, transhumanist thinkers, cosmists, futurists, AI researchers, cyberneticists, crypto enthusiasts, VR creators, artists, philosophers of mind. Accelerating now towards the Cybernetic Singularity with unprecedented advances in AI & Cybernetics, VR, Biotechnology, Nanotechnology, Bionics, Genetic Engineering, Optogenetics, Neuroengineering, Robotics, and other IT fields.

Join now: https://www.reddit.com/r/IntelligenceSupernova.

#Subreddit #IntelligenceSupernova

Mar 19, 2022

AI drug algorithms can be flipped to generate bioweapons

Posted by in categories: biotech/medical, information science, military, robotics/AI

What can heal can also be used to destroy?


MegaSyn is built to generate drug candidates with the lowest toxicity for patients. That got Urbina thinking. He retrained the model using data to drive the software toward generating lethal compounds, like nerve gas, and flipped the code so that it ranked its output from high-to-low toxicity. In effect, the software was told to come up with the most deadly stuff possible.

He ran the model and left it overnight to create new molecules.

Continue reading “AI drug algorithms can be flipped to generate bioweapons” »

Mar 18, 2022

Future evolution: from looks to brains and personality, how will humans change in the next 10,000 years?

Posted by in categories: biotech/medical, computing, food, genetics, information science, mobile phones, neuroscience

And going forward, we’ll do this with far more knowledge of what we’re doing, and more control over the genes of our progeny. We can already screen ourselves and embryos for genetic diseases. We could potentially choose embryos for desirable genes, as we do with crops. Direct editing of the DNA of a human embryo has been proven to be possible — but seems morally abhorrent, effectively turning children into subjects of medical experimentation. And yet, if such technologies were proven safe, I could imagine a future where you’d be a bad parent not to give your children the best genes possible.

Computers also provide an entirely new selective pressure. As more and more matches are made on smartphones, we are delegating decisions about what the next generation looks like to computer algorithms, who recommend our potential matches. Digital code now helps choose what genetic code passed on to future generations, just like it shapes what you stream or buy online. This might sound like dark science fiction, but it’s already happening. Our genes are being curated by computer, just like our playlists. It’s hard to know where this leads, but I wonder if it’s entirely wise to turn over the future of our species to iPhones, the internet and the companies behind them.

Discussions of human evolution are usually backward looking, as if the greatest triumphs and challenges were in the distant past. But as technology and culture enter a period of accelerating change, our genes will too. Arguably, the most interesting parts of evolution aren’t life’s origins, dinosaurs, or Neanderthals, but what’s happening right now, our present – and our future.

Mar 18, 2022

AI suggested 40,000 new possible chemical weapons in just six hours

Posted by in categories: biotech/medical, chemistry, military, robotics/AI

For me, the concern was just how easy it was to do. A lot of the things we used are out there for free. You can go and download a toxicity dataset from anywhere. If you have somebody who knows how to code in Python and has some machine learning capabilities, then in probably a good weekend of work, they could build something like this generative model driven by toxic datasets. So that was the thing that got us really thinking about putting this paper out there; it was such a low barrier of entry for this type of misuse.


AI could be just as effective in developing biochemical weapons as it is in identifying helpful new drugs, researchers warn.

Mar 18, 2022

Indian Startup Creates a Bionic Arm That’s 90% Cheaper

Posted by in categories: biotech/medical, cyborgs, transhumanism

An advanced bionic arm can be life-changing for a person with an upper limb amputation. But in India, with a population of nearly 1.4 billion and average income of just $2,000 a year, advanced prosthetics are financially out of reach for many amputees.

So the Indian startup Makers Hive developed one that’s not only 90% cheaper, but also more functional.

Advanced prosthetics: A bionic arm contains sensors that press against the skin of the wearer’s residual limb to detect electrical signals from their nerves.

Continue reading “Indian Startup Creates a Bionic Arm That’s 90% Cheaper” »

Mar 18, 2022

Scientists make leap forward for genetic sequencing

Posted by in categories: biotech/medical, genetics

In a paper published today in Sciences Advances, researchers in the Department of Chemistry and the Department of Physics & Astronomy at the University of California, Irvine revealed new details about a key enzyme that makes DNA sequencing possible. The finding is a leap forward into the era of personalized medicine when doctors will be able to design treatments based on the genomes of individual patients.

Mar 18, 2022

The beginning of a new paradigm for understanding the brain

Posted by in categories: biotech/medical, neuroscience

None.


In a new article published in eNeuro, fifteen leading scientists of the European Human Brain Project (HBP) outline how a new culture of collaboration and an era of digitalization has transformed neuroscience research over the last decade.

“The way we study the brain has changed fundamentally in recent years,” says first author Katrin Amunts, HBP Scientific Director, Director of the C. and O. Vogt-Institute of Brain Research, Düsseldorf and Director at the Institute of Neuroscience and Medicine at Research Centre Jülich. “In the past, separate communities have often focused on specific aspects of neuroscience, and the problem was always how to link the different worlds, for example, in order to explain a certain cognitive function in terms of the underlying neurobiology.”

Continue reading “The beginning of a new paradigm for understanding the brain” »

Mar 18, 2022

The coming decade of digital brain research — A vision for neuroscience at the intersection of technology and computing

Posted by in categories: biotech/medical, computing, neuroscience

Brain research has in recent years indisputably entered a new epoch, driven by substantial methodological advances and digitally enabled data integration and modeling at multiple scales – from molecules to the whole system. Major advances are emerging at the intersection of neuroscience with technology and computing. This new science of the brain integrates high-quality basic research, systematic data integration across multiple scales, a new culture of large-scale collaboration and translation into applications. A systematic approach, as pioneered in Europe’s Human Brain Project (HBP), will be essential in meeting the pressing medical and technological challenges of the coming decade.

Mar 17, 2022

Moderna seeks FDA authorization for 4th dose of COVID shot

Posted by in category: biotech/medical

WASHINGTON (AP) — Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.

The request is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.

In a press release, the company said its request for approval for all adults was made “to provide flexibility” to the Centers for Disease Control and Prevention and medical providers to determine the “appropriate use” of a second booster dose of the mRNA vaccine, “including for those at higher risk of COVID-19 due to age or comorbidities.”

Mar 17, 2022

Self-assembling and complex, nanoscale mesocrystals can be tuned for a variety of uses

Posted by in categories: biotech/medical, chemistry, nanotechnology, solar power

A research team from KTH Royal Institute of Technology and Max Planck Institute of Colloids and Interfaces reports to have found the key to controlled fabrication of cerium oxide mesocrystals. The research is a step forward in tuning nanomaterials that can serve a wide range of uses—including solar cells, fuel catalysts and even medicine.

Mesocrystals are nanoparticles with identical size, shape and crystallographic orientation, and they can be used as to create artificial nanostructures with customized optical, magnetic or electronic properties. In nature, these three-dimensional structures are found in coral, sea urchins and calcite desert rose, for example. Artificially-produced cerium oxide (CeO2) mesocrystals—or nanoceria—are well-known as catalysts, with antioxidant properties that could be useful in pharmaceutical development.

“To be able to fabricate CeO2 mesocrystals in a controlled way, one needs to understand the formation mechanism of these materials,” says Inna Soroka, a researcher in applied at KTH. She says the team used radiation chemistry to reveal for the first time the ceria mesocrystal formation mechanism.